Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments

12 September 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Read more

Oncology, the new era for biosimilar medicines

8 September 2017

With more than 10 years of positive experience and 700 […]

Read more

Europäer zahlen zu viel für Pillen

18 July 2017

Open

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Open

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Open

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Open

Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

16 June 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Read more

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

The European Semester Country Specific Recommendations show that healthcare systems […]

Read more

Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe

9 May 2017

The new report on The Impact of Biosimilar Competition in […]

Read more

Industry Welcomes the 3rd European Commission Workshop on Biosimilar Medicines

5 May 2017

The European pharmaceutical industry welcomes the 3rd workshop on access […]

Read more

Subscribe to our newsletter